| ACKNOWLEDGEMENTS | 第4-5页 |
| ABSTRACT | 第5-6页 |
| 摘要 | 第7-16页 |
| Chapter Ⅰ Introduction | 第16-22页 |
| 1.1 Research background | 第16-17页 |
| 1.2 Research problem | 第17-18页 |
| 1.3 Research contents and meanings | 第18-20页 |
| 1.3.1 Research contents | 第18-19页 |
| 1.3.2 Research meanings | 第19-20页 |
| 1.4 Research methods | 第20-22页 |
| 1.4.1 The theory analysis combined with case study | 第20-21页 |
| 1.4.2 Qualitative analysis methods | 第21-22页 |
| Chapter Ⅱ Theory and Literature Review | 第22-45页 |
| 2.1 The theory of M&A | 第22-28页 |
| 2.1.1 Theory of merger and acquisition | 第22-28页 |
| 2.2 The key concept definition | 第28-33页 |
| 2.2.1 Cross-border merger and acquisition | 第28-30页 |
| 2.2.2 Control right in cross-border merger and acquisition | 第30-32页 |
| 2.2.3 Performance of cross-border merger and acquisition | 第32-33页 |
| 2.3 M & A classification | 第33-36页 |
| 2.3.1 Dividing according to the industry relationship between acquirer and targetenterprise | 第33-34页 |
| 2.3.2 Dividing according to capital contribution | 第34-35页 |
| 2.3.3 Dividing according to the attitude of acquirer enterprise to the target enterprise | 第35页 |
| 2.3.4 Dividing according to whether the stock exchange publicly traded | 第35-36页 |
| 2.4 Research on cross-border M & A of scholars at home and abroad | 第36-45页 |
| 2.4.1 Research on the motivation of transnational merger and acquisition of enterprises | 第36-42页 |
| 2.4.2 Research on the choice of enterprise Cross-border M&A of the target region. | 第42-44页 |
| 2.4.3 Research on performance evaluation of enterprise cross-border M & A | 第44-45页 |
| Chapter Ⅲ The Present Situation of the Domestic Pharmaceutical Industry | 第45-62页 |
| 3.1 The present situation of the domestic pharmaceutical industry | 第45-54页 |
| 3.1.1 China's pharmaceutical industry characteristics and industrial pattern | 第45-47页 |
| 3.1.2 The domestic pharmaceutical industry market structure | 第47-51页 |
| 3.1.3 The size and number of domestic pharmaceutical enterprises | 第51-52页 |
| 3.1.4 Policy orientation of the domestic pharmaceutical enterprises | 第52-53页 |
| 3.1.5 International market and competition of pharmaceutical industry | 第53-54页 |
| 3.2 Activity of merger and acquisition of domestic enterprises | 第54-59页 |
| 3.2.1 The 2014 M & A trend | 第56-57页 |
| 3.2.2 Optimized function of M & A for the pharmaceutical industry | 第57-58页 |
| 3.2.3 M&A enhances the competitiveness of medical enterprises | 第58-59页 |
| 3.3 The development of the domestic pharmaceutical industry of cross-border mergers andacquisitions | 第59-62页 |
| 3.3.1 The progress of China's pharmaceutical industry M & A | 第59-60页 |
| 3.3.2 Characteristics of Chinese pharmaceutical industry M & A | 第60-62页 |
| Chapter Ⅳ Background of FOSUNPHARMA | 第62-72页 |
| 4.1 Company profile | 第62-66页 |
| 4.1.1 Relationship of enterprise group | 第63页 |
| 4.1.2 The development process of the company | 第63-65页 |
| 4.1.3 Industrial layout | 第65-66页 |
| 4.2 Development means | 第66-67页 |
| 4.3 Financial information | 第67-72页 |
| 4.3.1 The main financial data | 第68页 |
| 4.3.2 Operation situation of the reporting period | 第68-69页 |
| 4.3.3 Manufacturing and R & D of medicine | 第69-71页 |
| 4.3.4 Analysis of main business | 第71-72页 |
| ChapterⅤ Analysis of Cross-border M & A Cases of FOSUN PHARMA | 第72-85页 |
| 5.1 FOSUN PHARMA acquired Chindex | 第72-78页 |
| 5.1.1 Case background | 第72-73页 |
| 5.1.2 Type of M & A and strategic analysis | 第73-74页 |
| 5.1.3 Motivation analysis of M & A | 第74-75页 |
| 5.1.4 Analysis of the control right of M&A | 第75-76页 |
| 5.1.5 Performance evaluation | 第76-78页 |
| 5.2 FOSUN PHARMA acquired Israeli Alma Laser Ltd | 第78-83页 |
| 5.2.1 Case background | 第78-79页 |
| 5.2.2 Type of M & A and strategic analysis | 第79-80页 |
| 5.2.3 Motivation analysis of M & A | 第80-81页 |
| 5.2.4 Analysis of the control right of M&A | 第81-82页 |
| 5.2.5 Performance evaluation | 第82-83页 |
| 5.3 summary | 第83-85页 |
| Chapter Ⅵ Conclusion | 第85-88页 |
| 6.1 Summary of experience of FOSUN PHARMA M & A | 第85-87页 |
| 6.1.1 Implement vertical integration strategy, improve the industrial chain, and enhancethe competitiveness of the industry | 第85页 |
| 6.1.2 Realize synergies effect. Open up the international capital channel | 第85-86页 |
| 6.1.3 Focus on market segments, precisely positioning and optimizing the allocation ofresources | 第86-87页 |
| 6.2 conclusion | 第87-88页 |
| Reference | 第88-89页 |
